Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Cardiac Magnetic Resonance Imaging of Cardiac Amyloidosis.

Chao R, Ivanov A, Efthimiou P.

J Clin Rheumatol. 2018 Feb 22. doi: 10.1097/RHU.0000000000000693. [Epub ahead of print] No abstract available.

PMID:
29708515
2.

Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.

Feist E, Quartier P, Fautrel B, Schneider R, Sfriso P, Efthimiou P, Cantarini L, Lheritier K, Leon K, Karyekar CS, Speziale A.

Clin Exp Rheumatol. 2018 Mar 2. [Epub ahead of print]

3.

Tumor necrosis factor-associated periodic syndrome in adults.

Menon SG, Efthimiou P.

Rheumatol Int. 2018 Jan;38(1):3-11. doi: 10.1007/s00296-017-3820-4. Epub 2017 Sep 23. Review.

PMID:
28942479
4.

IgG4-related disease: a complex under-diagnosed clinical entity.

Yadlapati S, Verheyen E, Efthimiou P.

Rheumatol Int. 2018 Feb;38(2):169-177. doi: 10.1007/s00296-017-3765-7. Epub 2017 Jul 5. Review.

PMID:
28681251
5.

Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.

Bello AE, Perkins EL, Jay R, Efthimiou P.

Open Access Rheumatol. 2017 Mar 31;9:67-79. doi: 10.2147/OARRR.S131668. eCollection 2017. Review.

6.

Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?

Yadlapati S, Efthimiou P.

Biomed Res Int. 2016;2016:8631061. doi: 10.1155/2016/8631061. Epub 2016 Jun 27. Review.

7.

Inadequate response or intolerability to oral methotrexate: Is it optimal to switch to subcutaneous methotrexate prior to considering therapy with biologics?

Yadlapati S, Efthimiou P.

Rheumatol Int. 2016 May;36(5):627-33. doi: 10.1007/s00296-016-3447-x. Epub 2016 Mar 2. Review.

PMID:
26936262
8.

Screening Optimization of Latent Tuberculosis Infection in Rheumatoid Arthritis Patients.

Mehta B, Zapantis E, Petryna O, Efthimiou P.

Arthritis. 2015;2015:569620. doi: 10.1155/2015/569620. Epub 2015 Jul 29.

9.

Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.

Yadlapati S, Efthimiou P.

Mod Rheumatol. 2016;26(1):3-8. doi: 10.3109/14397595.2015.1069459. Epub 2015 Aug 3. Review.

PMID:
26140469
10.

Use of B lymphocyte stimulator inhibitor belimumab may be associated with a decrease in the serum concentration of epidermal growth factor in patients with primary Sjögren's syndrome.

Kadavath S, Bobic S, Efthimiou P.

Clin Rheumatol. 2015 Sep;34(9):1651-2. doi: 10.1007/s10067-015-2872-7. Epub 2015 Feb 5. Review.

PMID:
25652332
11.

Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.

Kadavath S, Efthimiou P.

Ann Med. 2015 Feb;47(1):6-14. doi: 10.3109/07853890.2014.971052. Epub 2015 Jan 22. Review.

PMID:
25613167
12.

A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.

Kadavath S, Zapantis E, Zolty R, Efthimiou P.

Int J Rheum Dis. 2014 Mar;17(3):336-40. doi: 10.1111/1756-185X.12324. Epub 2014 Feb 28. Review.

PMID:
24581387
13.

Life-threatening complications of adult-onset Still's disease.

Efthimiou P, Kadavath S, Mehta B.

Clin Rheumatol. 2014 Mar;33(3):305-14. doi: 10.1007/s10067-014-2487-4. Epub 2014 Jan 17. Review.

PMID:
24435354
14.

Can traumatic injury trigger psoriatic arthritis? A review of the literature.

Hsieh J, Kadavath S, Efthimiou P.

Clin Rheumatol. 2014 May;33(5):601-8. doi: 10.1007/s10067-013-2436-7. Epub 2013 Nov 19. Review.

PMID:
24249146
15.

Adult Onset Still's Disease and Autoinflammation.

Efthimiou P, Moorthy LN, Mavragani CP, Skokos D, Fautrel B.

Int J Inflam. 2012;2012:964751. doi: 10.1155/2012/964751. Epub 2012 Aug 29. No abstract available.

16.

IL-1 Trap rilonacept in refractory adult onset Still's disease.

Petryna O, Cush JJ, Efthimiou P.

Ann Rheum Dis. 2012 Dec;71(12):2056-7. doi: 10.1136/annrheumdis-2012-201409. Epub 2012 Jun 7. No abstract available.

PMID:
22679302
17.

Ferritin in adult-onset still's disease: just a useful innocent bystander?

Mehta B, Efthimiou P.

Int J Inflam. 2012;2012:298405. doi: 10.1155/2012/298405. Epub 2012 Mar 25. Erratum in: Int J Inflam. 2012;2012:254858.

18.

The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease.

Kontzias A, Efthimiou P.

Semin Arthritis Rheum. 2012 Oct;42(2):201-5. doi: 10.1016/j.semarthrit.2012.03.004. Epub 2012 Apr 17.

PMID:
22512815
19.

Radiographic improvement in sarcoid arthropathy after infliximab treatment.

Mehta B, Efthimiou P.

J Rheumatol. 2012 Mar;39(3):664-5. doi: 10.3899/jrheum.111002. No abstract available.

PMID:
22383361
20.

Lupus pernio: sarcoid-specific cutaneous manifestation associated with chronic sarcoid arthropathy.

Efthimiou P, Kukar M.

J Clin Rheumatol. 2011 Sep;17(6):343. doi: 10.1097/RHU.0b013e31822e0df0. No abstract available.

PMID:
21885927
21.

PCP chemoprophylaxis is essential for lymphopenic dermatomyositis patients treated with immunomodulators.

Efthimiou P, Pokharna H, Kukar M, Hennessey K.

Muscle Nerve. 2011 Jun;43(6):918-9. doi: 10.1002/mus.21997. Epub 2011 Apr 12. No abstract available.

PMID:
21488055
22.

Rituximab and lupus interstitial lung disease: friend or foe?

Efthimiou P, Kukar M, Hersh A.

Int J Rheum Dis. 2011 Feb;14(1):e3-4. doi: 10.1111/j.1756-185X.2010.01592.x. Epub 2011 Jan 24. No abstract available.

PMID:
21303472
23.

Headache from cavernous sinus thrombosis in Adamantiades-Behçet disease.

Efthimiou P, Petryna O.

J Clin Rheumatol. 2010 Dec;16(8):409. doi: 10.1097/RHU.0b013e31820059ca. No abstract available.

PMID:
21119387
24.

Clinical Image: posterior reversible encephalopathy syndrome as a severe manifestation of neuropsychiatric systemic lupus erythematosus.

Efthimiou P, Kukar M, Krishnan P.

Arthritis Rheum. 2010 Jun;62(6):1692. doi: 10.1002/art.27471. No abstract available.

25.

Images in rheumatology. Severe adult-onset calcinosis in a patient with a history of juvenile dermatomyositis.

Efthimiou P, Kukar M, Kagen LJ.

J Rheumatol. 2010 Jan;37(1):194. doi: 10.3899/jrheum.090628. No abstract available.

PMID:
20040639
26.

An unusual cause of lower back pain.

Petryna O, Efthimiou P.

J Rheumatol. 2009 Nov;36(11):2556. doi: 10.3899/jrheum.090498. No abstract available.

PMID:
19893061
27.

Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities.

Efthimiou P, Kukar M.

Rheumatol Int. 2010 Mar;30(5):571-86. doi: 10.1007/s00296-009-1206-y. Epub 2009 Oct 30. Review.

PMID:
19876631
29.

Complementary and alternative medicine in rheumatoid arthritis: no longer the last resort!

Efthimiou P, Kukar M, Mackenzie CR.

HSS J. 2010 Feb;6(1):108-11. doi: 10.1007/s11420-009-9133-8. Epub 2009 Sep 26.

30.

Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers.

Efthimiou P, Blanco M.

Mod Rheumatol. 2009;19(5):457-68. doi: 10.1007/s10165-009-0198-5. Epub 2009 Jul 18. Review.

PMID:
19618249
31.

Isolated severe vasculitic neuropathy revealing sarcoidosis.

Souayah N, Chodos A, Krivitskaya N, Efthimiou P, Lambert WC, Sharer LR.

Lancet Neurol. 2008 Aug;7(8):756-60. doi: 10.1016/S1474-4422(08)70166-2. No abstract available.

PMID:
18635023
32.

Autoinflammatory syndromes and infections: pathogenetic and clinical implications.

Efthimiou P, Flavell RA, Furlan A, Gasbarrini G, Gava A, Koné-Paut I, Manna R, Punzi L, Sutterwala FS, Touitou I, Doria A.

Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S53-61. Review.

PMID:
18570755
33.

Classic presentation of a rare disease: melorheostosis.

Efthimiou P, Nasis O, Russell LA.

J Rheumatol. 2008 Jun;35(6):1169. No abstract available.

PMID:
18528951
34.

Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.

Kontzias A, Efthimiou P.

Drugs. 2008;68(3):319-37. Review. Erratum in: Drugs. 2011 Oct 1;71(14):1820.

PMID:
18257609
35.

Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.

Efthimiou P, Blanco M.

Semin Arthritis Rheum. 2008 Dec;38(3):188-94. doi: 10.1016/j.semarthrit.2007.10.015. Epub 2008 Jan 25.

PMID:
18221985
36.

Aortic aneurysm in Takayasu's arteritis.

Efthimiou P, Nasis O, Lehman TJ.

J Rheumatol. 2007 Nov;34(11):2312. No abstract available.

PMID:
17985414
37.

Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?

Efthimiou P, Kontzias A, Ward CM, Ogden NS.

Nat Clin Pract Rheumatol. 2007 Jun;3(6):328-35. Review.

PMID:
17538564
38.

QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?

Efthimiou P, Sood S.

Ann Rheum Dis. 2007 Feb;66(2):276. Epub 2006 Nov 24. No abstract available.

39.

Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications.

Efthimiou P.

Semin Arthritis Rheum. 2006 Dec;36(3):168-72. Epub 2006 Sep 12. Review.

PMID:
16970978
40.

Pathogenesis and management of adult-onset Still's disease.

Efthimiou P, Georgy S.

Semin Arthritis Rheum. 2006 Dec;36(3):144-52. Epub 2006 Sep 1. Review.

PMID:
16949136
41.

Systemic and localized scleroderma in children: current and future treatment options.

Rosenkranz ME, Agle LM, Efthimiou P, Lehman TJ.

Paediatr Drugs. 2006;8(2):85-97. Review. Erratum in: Paediatr Drugs. 2006;8(4):270. Dosage error in article text.

PMID:
16608370
42.
43.

Management of musculoskeletal complications in endstage renal disease: an update.

Ramaswamy D, Efthimiou P, Gnanasekharan I, Soni A.

Clin Rheumatol. 2006 Jul;25(4):440-2. Epub 2005 Nov 3. Review.

PMID:
16267605
44.

Diagnosis and management of adult onset Still's disease.

Efthimiou P, Paik PK, Bielory L.

Ann Rheum Dis. 2006 May;65(5):564-72. Epub 2005 Oct 11. Review.

45.

Role of biological agents in immune-mediated inflammatory diseases.

Efthimiou P, Markenson JA.

South Med J. 2005 Feb;98(2):192-204. Review.

PMID:
15759950
46.

T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase.

Musch MW, Clarke LL, Mamah D, Gawenis LR, Zhang Z, Ellsworth W, Shalowitz D, Mittal N, Efthimiou P, Alnadjim Z, Hurst SD, Chang EB, Barrett TA.

J Clin Invest. 2002 Dec;110(11):1739-47.

Supplemental Content

Loading ...
Support Center